Joint (NASDAQ:JYNT) Shares Pass Below 200-Day Moving Average – Should You Sell?

The Joint Corp. (NASDAQ:JYNT) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $8.81 and traded as low as $8.67. Joint shares last traded at $8.67, with a volume of 34,249 shares traded.

Analyst Upgrades and Downgrades

JYNT has been the subject of a number of research reports. Weiss Ratings cut Joint from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday. Zacks Research lowered Joint from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 13th. Finally, Wall Street Zen upgraded Joint from a “hold” rating to a “buy” rating in a research note on Saturday. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Joint has a consensus rating of “Reduce” and an average price target of $18.00.

Joint Stock Performance

The stock has a 50 day simple moving average of $8.71 and a two-hundred day simple moving average of $8.81. The firm has a market cap of $124.44 million, a PE ratio of 37.78 and a beta of 1.11.

Joint (NASDAQ:JYNT) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. The business had revenue of $14.82 million during the quarter, compared to analyst estimates of $14.50 million. Joint had a return on equity of 6.58% and a net margin of 5.72%. Equities research analysts forecast that The Joint Corp. will post 0.31 earnings per share for the current year.

Insider Buying and Selling at Joint

In other Joint news, major shareholder Charles E. Jobson purchased 15,397 shares of the business’s stock in a transaction that occurred on Thursday, February 12th. The stock was purchased at an average price of $8.50 per share, for a total transaction of $130,874.50. Following the purchase, the insider directly owned 1,645,294 shares in the company, valued at approximately $13,984,999. This trade represents a 0.94% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last ninety days, insiders bought 16,354 shares of company stock valued at $139,139. 30.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Joint

Institutional investors and hedge funds have recently modified their holdings of the business. JCP Investment Management LLC increased its stake in shares of Joint by 24.0% in the 3rd quarter. JCP Investment Management LLC now owns 593,906 shares of the company’s stock valued at $5,666,000 after purchasing an additional 115,062 shares in the last quarter. Skylands Capital LLC increased its stake in shares of Joint by 6.9% in the 4th quarter. Skylands Capital LLC now owns 890,045 shares of the company’s stock valued at $7,761,000 after purchasing an additional 57,767 shares in the last quarter. Verus Capital Partners LLC increased its stake in shares of Joint by 1.7% in the 3rd quarter. Verus Capital Partners LLC now owns 113,426 shares of the company’s stock valued at $1,082,000 after purchasing an additional 1,947 shares in the last quarter. Stoneridge Investment Partners LLC purchased a new position in shares of Joint in the 3rd quarter valued at about $117,000. Finally, Strs Ohio increased its stake in shares of Joint by 17,300.0% in the 1st quarter. Strs Ohio now owns 17,400 shares of the company’s stock valued at $154,000 after purchasing an additional 17,300 shares in the last quarter. Hedge funds and other institutional investors own 76.88% of the company’s stock.

Joint Company Profile

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.